- Home
- ADVB
as 05-30-2025 4:00pm EST
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | RENO |
| Market Cap: | 36.1M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 197.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $4.10 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Advanced Biomed Inc. Common Stock News
ADVB Breaking Stock News: Dive into ADVB Ticker-Specific Updates for Smart Investing
MT Newswires
3 months ago
Advanced Biomed Closes $6.6 Million IPO
GlobeNewswire
3 months ago
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
GlobeNewswire
3 months ago
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Compare ADVB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADVB Advanced Biomed Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.